Hudson Bay Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Hudson Bay Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-102,357	Closed	-$924K	–	1621
2025 Q4	$924K	Buy	+102,357	New	+$765K	﹤0.01%	810
2025 Q3	–	Sell	-15,864	Closed	-$33.9K	–	1712
2025 Q2	$33.9K	Buy	+15,864	New	+$25.6K	﹤0.01%	1278
2023 Q4	–	Sell	-248,515	Closed	-$8.63M	–	905
2023 Q3	$8.63M	Buy	248,515 +153,000	+160%	+$5.29M	0.07%	182
2023 Q2	$3.13M	Buy	95,515 +28,515	+43%	+$983K	0.02%	416
2023 Q1	$2.24M	Buy	+67,000	New	+$2.61M	0.02%	504

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hudson Bay Capital Management's VTYX Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 102,357 shares — an estimated $924K sold.

Hudson Bay Capital Management first reported a position in VTYX in Q1 2023 and held it in 5 quarters. The position peaked at $8.63M in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Hudson Bay Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 102,357 Ventyx Biosciences shares in Q1 2026, an estimated $924K.
Hudson Bay Capital Management first reported a position in Ventyx Biosciences in Q1 2023 and held it in 5 quarters.
Hudson Bay Capital Management's Ventyx Biosciences position peaked at $8.63M in Q3 2023.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.